oxaliplatin [clinicaltrials_resource:463968301c095084fdaf9c99e77482e3]
Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer [clinicaltrials:NCT00003260]Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer [clinicaltrials:NCT00003287]Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer [clinicaltrials:NCT00003427]Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00004102]Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00004173]Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer [clinicaltrials:NCT00004187]Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00004206]Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004220]Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor [clinicaltrials:NCT00004243]Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer [clinicaltrials:NCT00004257]Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer [clinicaltrials:NCT00005035]Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005050]Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors [clinicaltrials:NCT00005068]Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction [clinicaltrials:NCT00005077]Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy [clinicaltrials:NCT00005836]Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical Cancer [clinicaltrials:NCT00005837]Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor [clinicaltrials:NCT00005839]Oxaliplatin in Treating Children With Advanced Solid Tumors [clinicaltrials:NCT00005844]Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum [clinicaltrials:NCT00005860]Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver [clinicaltrials:NCT00006050]Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction [clinicaltrials:NCT00006062]Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006115]Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [clinicaltrials:NCT00006117]Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy [clinicaltrials:NCT00006121]Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00006391]Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00006468]Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer [clinicaltrials:NCT00006479]Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer [clinicaltrials:NCT00008060]Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00008281]Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer [clinicaltrials:NCT00008294]Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00012389]Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer [clinicaltrials:NCT00016198]Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer [clinicaltrials:NCT00017082]Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer [clinicaltrials:NCT00019773]Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer [clinicaltrials:NCT00025142]Combination Chemotherapy in Treating Patients With Colorectal Cancer [clinicaltrials:NCT00039208]Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00039611]Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer [clinicaltrials:NCT00040820]Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer [clinicaltrials:NCT00043004]Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00049101]
intervention [clinicaltrials_vocabulary:intervention]
oxaliplatin [clinicaltrials_resource:463968301c095084fdaf9c99e77482e3]
Bio2RDF identifier
463968301c095084fdaf9c99e77482e3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:463968301c095084fdaf9c99e77482e3
intervention name [clinicaltrials_vocabulary:intervention-name]
oxaliplatin
identifier
clinicaltrials_resource:463968301c095084fdaf9c99e77482e3
title
oxaliplatin
@en
type
label
oxaliplatin [clinicaltrials_resource:463968301c095084fdaf9c99e77482e3]
@en